Showing results (3281-3290 of 6,517) with videos related to
Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|January 1, 1988
Recovery of a cell surface fetal antigen from circulating immune complexes of melanoma patientsJ H Wong, B Aguero, R K Gupta, et al.Cancer Immunology, Immunotherapy : CII|February 22, 2019
Melanoma-associated antigen-A and programmed death-ligand 1 expression are associated with advanced urothelial carcinomaIzak Faiena, Stephanie H Astrow, David A Elashoff, et al.Cancer Immunology, Immunotherapy : CII|March 11, 2019
Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trialBas D Koster, Saskia J A M Santegoets, Jorien Harting, et al.Cancer Immunology, Immunotherapy : CII|November 19, 2018
Upregulation of tumor PD-L1 by neoadjuvant chemoradiotherapy (neoCRT) confers improved survival in patients with lymph node metastasis of locally advanced rectal cancersShu-Fen Chiang, Chih-Yang Huang, Tao-Wei Ke, et al.Cancer Immunology, Immunotherapy : CII|November 16, 2018
A phase I clinical study of a cocktail vaccine of Wilms' tumor 1 (WT1) HLA class I and II peptides for recurrent malignant gliomaAkihiro Tsuboi, Naoya Hashimoto, Fumihiro Fujiki, et al.Cancer Immunology, Immunotherapy : CII|April 5, 2019
Unlocking the therapeutic potential of primary tumor-draining lymph nodesJossie Rotman, Bas D Koster, Ekaterina S Jordanova, et al.Cancer Immunology, Immunotherapy : CII|April 7, 2019
Heterogeneity of PD-L1 expression and CD8 tumor-infiltrating lymphocytes among subtypes of cutaneous adnexal carcinomasLucie Duverger, Amélie Osio, Bernard Cribier, et al.Cancer Immunology, Immunotherapy : CII|April 7, 2019
Modulation of NK cells with checkpoint inhibitors in the context of cancer immunotherapyBeatriz Sanchez-Correa, Nelson Lopez-Sejas, Esther Duran, et al.Cancer Immunology, Immunotherapy : CII|March 29, 2019
Correction to: Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trialBas D Koster, Saskia J A M Santegoets, Jorien Harting, et al.Cancer Immunology, Immunotherapy : CII|August 21, 2019
A VEGFR2-MICA bispecific antibody activates tumor-infiltrating lymphocytes and exhibits potent anti-tumor efficacy in miceYao Xu, Xinrong Zhang, Yong Wang, et al.Pageof 652